# Escitalopram Plus PS128 vs. Escitalopram

> **NCT04093960** · PHASE4 · TERMINATED · sponsor: **Kaohsiung Kai-Suan Psychiatric Hospital** · enrollment: 41 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus plantarum PS128

## Key facts

- **NCT ID:** NCT04093960
- **Lead sponsor:** Kaohsiung Kai-Suan Psychiatric Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-18
- **Primary completion:** 2019-03-04
- **Final completion:** 2019-09-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093960, "Escitalopram Plus PS128 vs. Escitalopram". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04093960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
